I believe this is more controlled by either CME or ICE winning the licensing bid from LSE. http://www.reuters.com/article/cme-lse-ice-idUSL1N10E2JZ20150803
I look forward to having the TF back at the CME, and hopefully they will align the hours with the rest of the stock indicies.
I don't trade it actively every day but I do trade it from time to time on ICE. It's perfectly fine other than low liquidity during Asian/Euro session.
Yes but it was sort'uv covered-up due to the fact the other Eminis were doing the same. The main difference was the volatility...it slowed considerably while the other Eminis maintained their volatility. In contrast, current environment...all the Eminis have poor volatility. Thus, I don't expect much improvement in TF when it moves back from ICE to the CME. Hopefully I'm wrong. I expect the CME gives its professional clients a deal on TF to attract them back (those they lost) or at least remove the high fees that was slapped on by ICE. We really don't know the behind scenes about the ICE wanting that product and now selling it back...just guesses unless someone can link the behind scenes info to understand those folks that run the CME and ICE involving TF.
Thank you very much for the link...very interesting. I've searched news before about the Russell products and obviously I missed this link.